Eupraxia Pharmaceuticals (EPRX) Times Interest Earned (2023 - 2024)

Eupraxia Pharmaceuticals (EPRX) has reported Times Interest Earned for 3 consecutive years, with -$908.88 the latest figure, recorded in Q4 2025.

• In Q4 2025, Times Interest Earned fell 17248.38% year-over-year to -$908.88; the TTM figure through Dec 2025 stood at -$2100.1 (down 5402.53% YoY), while the FY2025 annual figure was $0.11, down 38.13% from the prior year.
• Times Interest Earned retreated to -$908.88 in Q4 2025 per EPRX's latest filing, from -$5.24 in the prior quarter.
• Across five years, Times Interest Earned topped out at $13285.5 in Q3 2024 and bottomed at -$908.88 in Q4 2025.
• Historically, Times Interest Earned has averaged $2481.2 across 3 years, with a median of $14.57 in 2023.
• Annual changes were most pronounced in 2024 — Times Interest Earned surged 38.32% — and 2025, when it tumbled 17248.38%.
• Eupraxia Pharmaceuticals' Times Interest Earned stood at $14.57 in 2023, then slumped by 135.95% to -$5.24 in 2024, then sank by 17248.38% to -$908.88 in 2025.
• Business Quant data shows EPRX's Times Interest Earned at -$908.88 in Q4 2025, -$5.24 in Q4 2024, and $13285.5 in Q3 2024.